Milner Institute joins BioCentury’s Grand Rounds Europe conference
The Milner Institute was proud to take part in BioCentury’s Grand Rounds Europe conference in Cambridge this month. Over three days of keynotes, fireside chats, panel discussions and networking sessions, Grand Rounds fostered meaningful dialogue, inspired new ideas,...
Daiichi Sankyo joins Milner Therapeutics Consortium
We are delighted to announce that Daiichi Sankyo has joined the Milner Therapeutics Consortium as our tenth pharma partner. The Milner team works closely with this unique grouping of pharma companies to advance research towards new therapeutics across multiple disease...
Milner Institute welcomes local MPs to explore research and innovation
Last week, we were delighted to welcome Pippa Heylings MP, Charlotte Cane MP and Councillor Olaf Hauk to the Milner Therapeutics Institute. The visit provided an opportunity to showcase our mission and impact, including our pioneering research, collaborations with...
Milner Head of AI expands role across Milner Institute and Yonsei University
We are delighted to share that Dr Namshik Han, Head of AI and Computational Research at the Milner Therapeutics Institute, has begun a new role as Professor at Yonsei University in Seoul, South Korea. Namshik will divide his time between Yonsei University and the...